Cargando…
Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives
X-linked hypophosphatemia (XLH) is a rare, progressive, genetic disease with multisystem impact that typically begins to manifest in early childhood. Two treatment options exist: oral phosphate in combination with active vitamin D (“conventional therapy”) and a fully human monoclonal anti-FGF23 anti...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400326/ https://www.ncbi.nlm.nih.gov/pubmed/37547321 http://dx.doi.org/10.3389/fendo.2023.1211426 |